Related Experiment Video
Updated: Nov 12, 2025
05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
7.0K
Addiction Transfer and Other Behavioral Changes Following Bariatric Surgery
Afton M Koball1, Gretchen Ames2, Rachel E Goetze3
1Behavioral Medicine, Gundersen Health System, 1900 South Avenue, La Crosse, WI 54601, USA.
The Surgical Clinics of North America
|March 21, 2021
Summary
Bariatric surgery necessitates significant behavioral shifts, including potential addiction transfer. Comprehensive psychological evaluation and ongoing support are crucial for successful outcomes and managing risks post-surgery.
Area of Science:
- Behavioral science
- Psychiatry
- Bariatric medicine
Background:
- Bariatric surgery is a key intervention for obesity and related conditions.
- Successful outcomes depend on substantial patient behavioral changes.
- Pre- and post-operative psychological support is essential.
Purpose of the Study:
- To review emerging evidence on addiction transfer post-bariatric surgery.
- To examine other behavioral changes affecting surgical outcomes.
- To provide recommendations for psychological evaluations and support.
Main Methods:
- Literature review of scientific and anecdotal evidence.
- Analysis of behavioral changes impacting adherence, weight loss, and psychiatric risk.
- Synthesis of current practices and future recommendations.
Main Results:
- Evidence suggests addiction transfer is a potential post-bariatric surgery phenomenon.
- Various behavioral changes significantly influence patient adherence and weight management.
- Psychiatric risks are associated with these behavioral shifts.
Conclusions:
- Presurgical psychological evaluation is vital for identifying at-risk individuals.
- Postoperative support is necessary to manage behavioral changes and mitigate risks.
- Addressing addiction transfer and other behavioral factors improves bariatric surgery success.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
84
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
84
01:23Binge Eating Disorders
263
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
263
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
69
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
69
01:30Bulimia Nervosa
326
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
326
01:29Chronic Pancreatitis II: Collaborative Care
168
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
168
01:21Drug Dosing: Obese Patients
73
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
73